title: rRNA mutants in the yeast peptidyltransferase center reveal allosteric information networks and mechanisms of drug resistance.
abstract: To ensure accurate and rapid protein synthesis, nearby and distantly located functional regions of the ribosome must dynamically communicate and coordinate with one another through a series of information exchange networks. The ribosome is approximately 2/3 rRNA and information should pass mostly through this medium. Here, two viable mutants located in the peptidyltransferase center (PTC) of yeast ribosomes were created using a yeast genetic system that enables stable production of ribosomes containing only mutant rRNAs. The specific mutants were C2820U (Escherichia coli C2452) and Psi2922C (E. coli U2554). Biochemical and genetic analyses of these mutants suggest that they may trap the PTC in the 'open' or aa-tRNA bound conformation, decreasing peptidyl-tRNA binding. We suggest that these structural changes are manifested at the biological level by affecting large ribosomal subunit biogenesis, ribosomal subunit joining during initiation, susceptibility/resistance to peptidyltransferase inhibitors, and the ability of ribosomes to properly decode termination codons. These studies also add to our understanding of how information is transmitted both locally and over long distances through allosteric networks of rRNA-rRNA and rRNA-protein interactions.
authors.affiliation: Department of Cell Biology and Molecular Genetics, University of Maryland, 2135 Microbiology Building, College Park, MD 20742, USA.
authors.forename: Rasa
authors.initials: R
authors.lastname: Rakauskaite
authors.forename: Jonathan D
authors.initials: JD
authors.lastname: Dinman
mesh_terms: D000494:Allosteric Regulation; D000841:Anisomycin / Q000494:pharmacology; D001483:Base Sequence; D018388:Codon, Terminator; D004351:Drug Resistance; D008969:Molecular Sequence Data; D009154:Mutation; D010303:Paromomycin / Q000494:pharmacology; D010458:Peptidyl Transferases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D011328:Prions / Q000378:metabolism; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology*; D012335:RNA, Ribosomal / Q000737:chemistry* / Q000235:genetics; D012343:RNA, Transfer / Q000378:metabolism; D054683:Ribosome Subunits, Large, Eukaryotic / Q000378:metabolism; D012270:Ribosomes / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism; D013033:Sparsomycin / Q000494:pharmacology; D015003:Yeasts / Q000201:enzymology / Q000235:genetics
chemical_list: D018388:Codon, Terminator; D011328:Prions; D011500:Protein Synthesis Inhibitors; D012335:RNA, Ribosomal; C065039:RNA, ribosomal, 25S; D010303:Paromomycin; D000841:Anisomycin; D013033:Sparsomycin; D012343:RNA, Transfer; D010458:Peptidyl Transferases